NCT04303975

The Association of hsCRP and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma

An Explorative Study on the Association of High Sensitivity C-Reactive Protein (hsCRP) and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 300 (estimated)
• Sponsor: Jiarong Chen, MD · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: —

Summary

The primary purpose of this study is to explore the association of high sensitivity C-reactive protein (hsCRP) and radiotherapy(RT)-induced toxicity in patients with nasopharyngeal carcinoma. In each patient, hsCRP levels in the pre- and post-RT plasma samples will be measured according to the schedule we set.

Conditions

• Nasopharyngeal Carcinoma
• Head and Neck Cancer
• Toxicity Due to Radiotherapy

Interventions

Type	Name	Description
OTHER	clinical measurements	Only clinical parameters were recorded, no intervention was made.

Timeline

• Start date: 2021-06-01
• Primary completion: 2021-12-01
• Completion: 2021-12-01
• First posted: 2020-03-11
• Last updated: 2020-06-11